Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company
Schiller
Ampronix

Dilon Acquires Navigator Gamma Probe Company

By Medimaging International staff writers
Posted on 13 Jan 2014
Dilon Technologies, Inc. (Newport News, VA, USA) has acquired the assets of the Navigator gamma probe business from RMD Instruments Corp. (Watertown, MA, USA), a subsidiary of Dynasil Corporation of America.

RMD Instruments manufactures and sells a range of intraoperative surgical probes that are distributed both in the United States and worldwide. The acquired products are used in surgery for procedures such as pulmonary wedge resection and sentinel lymph node biopsy. The company recently introduced its Navigator 2.0 wireless probe, which has been very well received by the market place.

“In addition to our market leadership in the small field-of-view molecular breast imaging market, this acquisition is consistent with our objective of expanding our product offering in both the diagnostic and surgical segments of the market and comes on the heels of our recent agreement with Digirad [Suwanee, GA, USA],” commented Robert G. Moussa, Dilon’s CEO.

“We are pleased to have found a wonderful home for our Navigator Probe technology, one of the most widely used gamma probes for cancer surgery in the marketplace. Dilon Technologies is well situated to expand the gamma probe market and we look forward to working with them over the coming months to transition the product from our manufacturing facility to Dilon,” commented Peter Sulick, Dynasil’s chairman and interim CEO.

Dynasil, for the time being, will continue to manufacture and distribute the products, maintaining continuity in supply and regulatory compliance.

Dilon Technologies’ keystone product, the Dilon molecular imaging system (MBI), is a high-resolution, small field-of-view digital gamma camera, optimized for MBI/breast-specific gamma imaging (BSGI). MBI utilizes radiotracer uptake to detect the increased metabolic activity of breast lesions and therefore, is not affected by breast density. Both the Dilon 6800 and Acella systems provide high photon sensitivity; and Dilon’s GammaLoc system is the only localization device on the market to enable molecular-guided breast biopsy.

Digirad is one of the largest US providers of in-office nuclear cardiology imaging and ultrasound services to physician practices, hospitals and imaging centers, and also sells medical diagnostic imaging systems for nuclear cardiology and general nuclear medicine applications.

Related Links:

Dilon Technologies
RMD Instruments
Digirad



Channels

MRI

view channel
Image: Siemens Healthcare MAGNETOM Avanto 1.5-T MRI Scanner (Photo courtesy of Siemens Healthcare).

MRI Technique Allows for “Fingerprinting” of Tissues and Diseases for Faster Diagnoses

New findings published in the journal Nature indicate that a new Magnetic Resonance Imaging (MRI) technique, called Magnetic Resonance Fingerprinting (MRF), could provide much more information with each... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).

Oncology Software Update Compliant with New BTS Guidelines

A key diagnostic imaging vendor has announced that it has modified its oncology software solution to ensure compliance with new British Thoracic Society (BTS) guidelines for lung nodule screening.... Read more
 

Events

11 Sep 2015 - 12 Sep 2015
19 Sep 2015 - 24 Sep 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.